0000899243-19-006454.txt : 20190306
0000899243-19-006454.hdr.sgml : 20190306
20190306164530
ACCESSION NUMBER: 0000899243-19-006454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUEHL DANIEL W
CENTRAL INDEX KEY: 0001283569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 19663085
MAIL ADDRESS:
STREET 1: 5 BILLERICA PARK
STREET 2: 101 BILLERICA AVE
CITY: NORTH BILLERCA
STATE: MA
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-05
0
0001466301
Clovis Oncology, Inc.
CLVS
0001283569
MUEHL DANIEL W
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2019-03-05
4
M
0
469
A
6414
D
Common Stock
2019-03-05
4
S
0
237
29.29
D
6177
D
Common Stock
2019-03-05
4
M
0
2250
A
8427
D
Common Stock
2019-03-05
4
S
0
1060
29.29
D
7367
D
Restricted Stock Units
2019-03-05
4
M
0
469
0.00
D
Common Stock
469
3750
D
Restricted Stock Units
2019-03-05
4
M
0
2250
0.00
D
Common Stock
2250
6750
D
Each Restricted Stock Unit represents the right to receive one share of Common Stock.
Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
On March 1, 2018, the reporting person was granted 9,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Executive Vice President of Finance, Principal Financial Officer and Principal Accounting Officer
/s/ Daniel W. Muehl
2019-03-06